产品
编 号：F756679
分子式：C23H24F2N4O2S
分子量：458.52
分子式：C23H24F2N4O2S
分子量：458.52
产品类型
规格
价格
是否有货
结构图
CAS No: 2892451-17-9
产品详情
生物活性：
LRRK2-IN-6 (compound 22) is a potent, orally active, selective leucine rich repeat protein kinase 2 gene (LRRK2) inhibitor with IC50 values of 4.6 and 49 μM for GS LRRK2 and WT LRRK2, respectively. LRRK2-IN-6 inhibits LRRK2 Ser1292 and Ser925 autophosphorylation. LRRK2-IN-6 can cross the blood-brain barrier.
体内研究：
LRRK2-IN-6 (compound 22; 0.5 mg/kg (i.v.) and 5 mg/kg (p.o.); CD-1 mice) has good pharmacokinetic parametershigh and high bioavailability.Animal Model:CD-1 mice
Dosage:0.5 mg/kg (i.v.) and 5 mg/kg (p.o.)
Administration:Intravenous injection and oral administration
Result:1.19Route of AdministrationIVPO
Dose (mg/kg)0.55
AUCinf (μM*h)0.7111.9
Cmax (μM)0.531.86
Tmax (h)0.081.33
T1/2 (h)1.095.40
MRT (h)1.176.40
CL (mL/min)26.1
F (%)174
体外研究：
LRRK2-IN-6 (compound 22; 0-10000 nM; 24 h; HEK293 cells) has excellent potency and GS-LRRK2 selectivity.
LRRK2-IN-6 (compound 22) is a potent, orally active, selective leucine rich repeat protein kinase 2 gene (LRRK2) inhibitor with IC50 values of 4.6 and 49 μM for GS LRRK2 and WT LRRK2, respectively. LRRK2-IN-6 inhibits LRRK2 Ser1292 and Ser925 autophosphorylation. LRRK2-IN-6 can cross the blood-brain barrier.
体内研究：
LRRK2-IN-6 (compound 22; 0.5 mg/kg (i.v.) and 5 mg/kg (p.o.); CD-1 mice) has good pharmacokinetic parametershigh and high bioavailability.Animal Model:CD-1 mice
Dosage:0.5 mg/kg (i.v.) and 5 mg/kg (p.o.)
Administration:Intravenous injection and oral administration
Result:1.19Route of AdministrationIVPO
Dose (mg/kg)0.55
AUCinf (μM*h)0.7111.9
Cmax (μM)0.531.86
Tmax (h)0.081.33
T1/2 (h)1.095.40
MRT (h)1.176.40
CL (mL/min)26.1
F (%)174
体外研究：
LRRK2-IN-6 (compound 22; 0-10000 nM; 24 h; HEK293 cells) has excellent potency and GS-LRRK2 selectivity.
产品资料
Copyright©2015-2024 沪ICP备2022026524号-1
沪公网安备